Cytomegalovirus viraemia has poor predictive value for the development of Cytomegalovirus disease in patients with advanced HIV-infection

Journal of Infection

Volumn 39, Issue 3, 1999, Pages 187-192

  Wiselka, Martin J ^a   Nicholson, Karl G ^a   Rowley, Stephen ^a   Bibby, Kim ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; ESOPHAGITIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PROSPECTIVE STUDY; RETINITIS; VIREMIA;

EID: 0033378498     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(99)90047-6     Document Type: Article

References (27)

1. Jacobson MA, O'Donnell JJ, Porteous D et al. Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome. Prevalence, natural history, and response to ganciclovir therapy. Q J Med 1988; 254: 473-486.
2. Hoover DR, Saah AJ, Bacellar H et al. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. N Engl J Med 1993; 329: 1922-1926.
3. Jabs DA, Green WR, Fox R et al. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology 1989; 96: 1092-1099.
4. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1989; 107: 75-80.
5. Gross JG, Bozzette SA, Matthews WC et al. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1990; 97: 681-686.
6. Holland GN, Sison RF, Jatulis DE, et al. Survival of patients with the acquired immune deficiency syndrome after developing cytomegalovirus retinopathy. Ophthalmology 1990; 97: 204-211.
7. Bloom JN, Palestine AG. The diagnosis of cytomegalovirus retinitis. Am Int Med 1988; 109: 963-969.
8. Matthews T, Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 1988; 10: S490-S494.
9. Collaborative DHPG Treatment Study Group. Treatment of serious cytomegalovirus infections with 9-(1,-3-dihydroxy-2-propoxymethyl) guanine in patients with AIDS and other immunodeficiencies. N Engl J Med 1986; 314: 801-805.
10. Jacobson MA, O'Donnell JJ, Brodie HR et al. Randomised prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis. J Med Virol 1988; 25: 339-349.
11. Aweeka F, Gambertoglio J, Mills J et al. Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immune deficiency syndrome patients with serious cytomegalovirus retinitis. Antimicrob Agents Chemother 1989; 33: 742-745.
12. Jacobson MA, O'Donnell JJ, Mills J. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immune deficiency syndrome. Antimicrob Agents Chemother 1989; 33: 736-741.
13. Fanning MM, Read SE, Benson M et al. Foscarnet therapy of cytomegalovirus retinitis in AIDS. J AIDS 1990; 3: 472-479.
14. Lalezari JP, Stagg RJ, Kuppermann BD et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized controlled trial. Ann Int Med 1997; 126: 257-63.
15. Atkinson K, Downs K, Golenia M et al. Prophylactic use of ganciclovir in allogenic bone marrow transplantation: absence of clinical cytomegalovirus infection. Br J Haematol 1991; 79: 57-62.
16. Schmidt GM, Horak DA, Niland JC et al. A randomised, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 1991; 324: 1005-1011.
17. Spector SA, McKinley GF, Lalczari JP et al. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. N Engl J Med 1996; 334: 1491-1497.
18. Dunn JP, MacCumber HW, Forman MS, Charache P, Apuzzo L, Jabs DA. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir. Am J Ophthalmol 1995; 119: 587-596.
19. Erice A, Chou S, Biron KK et al. Progressive disease due to ganciclovir resistant cytomegalovirus in immunocompromised patients. N Engl J Med 1989; 320: 289-293.
20. Drew WL, Miner R, Busch D et al. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis 1991; 163: 716-719.
21. Bibby K, Rosenthal AR, Nicholson KG, Wiselka MJ. Once weekly ganciclovir as prophylaxis is unacceptable to patients. Sexually Transmitted Infections 1998; 74: 160-161.
22. Francisci DF, Tosti A, Baldelli F, Stagni G, Pauluzzi S. The pp65 antigenaemia test as a predictor of cytomegalovirus-induced end-organ damage in patients with AIDS. AIDS 1997; 11: 1341-1345.
23. Hansen KK, Ricksten A, Hofman B, Norrild B, Olofsson S, Mathiesen L. Detection of cytomegalovirus DNA in serum correlates with clinical cytomegalovirus retinitis in AIDS. J Int Dis 1994; 170: 1271-1274.
24. Bowen EF, Wilson P, Cope A et al. Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival. AIDS 1996; 10: 1515-1520.
25. Dodt KE, Jacobsen PH, Hofman B et al. Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test. AIDS 1997; 11:F21-F28.
26. Shinkai M, Bozzette SA, Powderly, Frame P, Spector SA. Utility of urine and leucocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. J Int Dis 1997; 175: 302-308.
27. Bowen EF, Sabin CA, Wilson P et al. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS 1997; 11: 889-893.